SORRENTO THERAPEUTICS INC's ticker is and the CUSIP is 83587F952. A total of 7 filers reported holding SORRENTO THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $332,000 | -59.0% | 71,400 | -14.6% | 0.00% | -100.0% |
Q2 2021 | $810,000 | +8.7% | 83,600 | -7.2% | 0.00% | 0.0% |
Q1 2021 | $745,000 | -57.6% | 90,100 | -65.0% | 0.00% | -50.0% |
Q4 2020 | $1,759,000 | -52.1% | 257,700 | -21.8% | 0.00% | -66.7% |
Q3 2020 | $3,676,000 | +137.8% | 329,700 | +34.0% | 0.01% | +100.0% |
Q2 2020 | $1,546,000 | – | 246,100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SABBY MANAGEMENT, LLC | 9,164 | $6,254,000 | 1.20% |
Athanor Capital, LP | 150,000 | $1,024,000 | 0.02% |
GROUP ONE TRADING, L.P. | 733,500 | $5,006,000 | 0.01% |
SIMPLEX TRADING, LLC | 3,306 | $2,256,000 | 0.00% |
IMC-Chicago, LLC | 257,700 | $1,759,000 | 0.00% |
JPMORGAN CHASE & CO | 39,500 | $270,000 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |